Clinical
RSSArticles
-
Identify and Treat Urologic Injuries at Hysterectomy to Reduce Fistulas
In a large population-based cohort study, genitourinary fistulas were increased significantly if ureteral and/or bladder injuries were not identified and treated at the time of hysterectomy.
-
Patients' Views on Adverse Events Following Pelvic Reconstructive Surgery
Patients see poor functional outcomes as severe adverse events following pelvic floor surgery.
-
Should Obesity Be a Contraindication to Postpartum Tubal Sterilization?
In this retrospective cohort study of 279 women undergoing postpartum partial salpingectomy after vaginal delivery, the mean operative time for women with a BMI ≥ 30 kg/m2 was only 5.5 minutes longer than the time for women with a BMI < 30 kg/m2.
-
Is There Group Beating?
How should one proceed in analyzing this challenging rhythm strip?
-
Dupilumab Injection (Dupixent)
This is the first FDA-approved treatment for chronic rhinosinusitis with nasal polyposis.
-
Mechanism of Persistence of Moraxella catarrhalis in Patients With COPD
Investigators examined the mechanism that allows Moraxella catarrhalis to persist in some patients with COPD.
-
Early vs. Delayed Cardioversion: A Nonshocking Result
For patients presenting to an ED with recent-onset atrial fibrillation, using rate control and outpatient cardioversion only as needed was associated with a high rate of spontaneous conversion within 48 hours of arrhythmia onset and noninferior short-term outcomes compared to immediate cardioversion in the ED.
-
Mind-Body Techniques May Enhance Cognitive Fitness in Older Adults
A meta-analysis regarding mind-body techniques and cognitive fitness in older adults points to enhanced cognitive performance associated with mind-body interventions in older patients, especially those without preexisting cognitive decline.
-
New Target May Lead to Chlamydia Treatment Options
Reproductive health providers battle against chlamydia every day, as it is the most commonly reported sexually transmitted infection in the U.S. According to data from the CDC, more than 1.7 million cases were diagnosed in 2017, with 45% among females ages 15-24 years. New research has identified a potential target for drug treatment that may help develop alternate approaches to stem infections.
-
HIV Screening, PrEP Receive USPSTF Recommendation
The U.S. Preventive Services Task Force (USPSTF) has issued final recommendations that providers screen for HIV in everyone ages 15-65 years, and all pregnant women as well as younger adolescents and older adults at increased risk for HIV. Pre-exposure prophylaxis (PrEP) also should be offered to people at high risk of HIV, USPSTF recommends. Since 2006, the CDC has recommended universal HIV screening at least once for people ages 13-64 years, with annual or more frequent rescreenings for persons at increased risk. However, new data indicate that such recommendations have not been fully implemented.